Conformation-dependent antibodies target diseases of protein misfolding

Trends in Biochemical Sciences

Volumn 29, Issue 10, 2004, Pages 542-547

  Glabe, Charles G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; ANTIBODY; OLIGOMER;

ANTIBODY SPECIFICITY; CONFORMATION; FIBER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW;

AMYLOID; ANTIBODIES; MOLECULAR CONFORMATION; PHARMACEUTICAL PREPARATIONS; PROTEIN DENATURATION; PROTEIN FOLDING; STRUCTURE-ACTIVITY RELATIONSHIP; VACCINES;

EID: 4644293577     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2004.08.009     Document Type: Review

References (52)

1. D.A. Kirschner X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-β conformation Proc. Natl. Acad. Sci. U. S. A. 83 1986 503 507; erratum in Proc. Natl. Acad. Sci. U. S. A. 83, 2776
2. D.A. Kirschner Synthetic peptide homologous to β protein from Alzheimer disease forms amyloid-like fibrils in vitro Proc. Natl. Acad. Sci. U. S. A. 84 1987 6953 6957
3. T.L. Benzinger Propagating structure of Alzheimer's β-amyloid(10-35) is parallel β-sheet with residues in exact register Proc. Natl. Acad. Sci. U. S. A. 95 1998 13407 13412
4. J.J. Balbach Supramolecular structure in full-length Alzheimer's β-amyloid fibrils: evidence for a parallel β-sheet organization from solid- state nuclear magnetic resonance Biophys. J. 83 2002 1205 1216
5. O.N. Antzutkin Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of β-sheets in Alzheimer's β-amyloid fibrils Proc. Natl. Acad. Sci. U. S. A. 97 2000 13045 13050
6. M. Torok Structural and dynamic features of Alzheimer's Aβ peptide in amyloid fibrils studied by site-directed spin labeling J. Biol. Chem. 277 2002 40810 40815
7. A. Der-Sarkissian Structural organization of α-synuclein fibrils studied by site-directed spin labeling J. Biol. Chem. 278 2003 37530 37535
8. S. Barghorn Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on β-structure in the core domain Biochemistry 43 2004 1694 1703
9. M. Margittai, and R. Langen Template-assisted filament growth by parallel stacking of tau Proc. Natl. Acad. Sci. U. S. A. 101 2004 10278 10283
10. 16-22, a seven-residue fragment of the Alzheimer's β-amyloid peptide, and structural characterization by solid state NMR Biochemistry 39 2000 13748 13759
11. A.T. Petkova Solid State NMR Reveals a pH-dependent antiparallel β-sheet registry in fibrils formed by a β-amyloid peptide J. Mol. Biol. 335 2004 247 260
12. C.M. Dobson Protein misfolding, evolution and disease Trends Biochem. Sci. 24 1999 329 332
13. B. Soreghan Surfactant properties of Alzheimer's Aβ peptides and the mechanism of amyloid aggregation J. Biol. Chem. 269 1994 28551 28554
14. J.D. Harper, and P.T. Lansbury Jr Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins Annu. Rev. Biochem. 66 1997 385 407
15. A. Lomakin Kinetic theory of fibrillogenesis of amyloid β-protein Proc. Natl. Acad. Sci. U. S. A. 94 1997 7942 7947
16. J.D. Harper Observation of metastable Aβ amyloid protofibrils by atomic force microscopy Chem. Biol. 4 1997 119 125
17. D.M. Walsh Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediate J. Biol. Chem. 272 1997 22364 22372
18. 1-42 are potent central nervous system neurotoxins Proc. Natl. Acad. Sci. U. S. A. 95 1998 6448 6453
19. 1-40: implications for the search for Aβ fibril formation inhibitors J. Struct. Biol. 130 2000 217 231
20. K.A. Conway Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid Biochemistry 39 2000 2552 2563
21. J. Janson The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles Diabetes 48 1999 491 498
22. M. Bucciantini Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 416 2002 507 511
23. D.M. Walsh Amyloid-β oligomers: their production, toxicity and therapeutic inhibition Biochem. Soc. Trans. 30 2002 552 557
24. H.A. Lashuel Neurodegenerative disease: amyloid pores from pathogenic mutations Nature 418 2002 291
25. M. Anguiano Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes Biochemistry 41 2002 11338 11343
26. E.S. Cathcart Antigenic determinants in amyloid deposits Nature 228 1970 1090 1091
27. C. Isersky Murine amyloidosis: immunologic characterization of amyloid fibril protein J. Immunol. 107 1971 1690 1698
28. E.C. Franklin, and D. Zucker-Franklin Antisera specific for human amyloid reactive with conformational antigens Proc. Soc. Exp. Biol. Med. 140 1972 565 568
29. R.P. Linke Morphologic, chemical, and immunologic studies of amyloid-like fibrils formed from Bence Jones proteins by proteolysis J. Immunol. 111 1973 10 23
30. B.L. Wolozin A neuronal antigen in the brains of Alzheimer patients Science 232 1986 648 650
31. G. Carmel The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology J. Biol. Chem. 271 1996 32789 32795
32. N. Ghoshal Tau-66: evidence for a novel tau conformation in Alzheimer's disease J. Neurochem. 77 2001 1372 1385
33. G.A. Jicha A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease J. Neurochem. 69 1997 2087 2095
34. 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells J. Biol. Chem. 270 1995 14786 14792
35. B. Soreghan The influence of the carboxyl terminus of the Alzheimer Aβ peptide on its conformation, aggregation, and neurotoxic properties Neuromol. Med. 1 2002 81 94
36. B.A. Bahr Amyloid β protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxy-terminal fragments of the amyloid precursor protein J. Comp. Neurol. 397 1998 139 147
37. R.H. Takahashi Oligomerization of Alzheimer's β-amyloid within processes and synapses of cultured neurons and brain J. Neurosci. 24 2004 3592 3599
38. M.P. Lambert Vaccination with soluble Aβ oligomers generates toxicity-neutralizing antibodies J. Neurochem. 79 2001 595 605
39. Y. Gong Alzheimer's disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss Proc. Natl. Acad. Sci. U. S. A. 100 2003 10417 10422
40. S.B. Prusiner Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies Proc. Natl. Acad. Sci. U. S. A. 90 1993 10608 10612
41. R.A. Williamson Mapping the prion protein using recombinant antibodies J. Virol. 72 1998 9413 9418
42. J.G. Safar Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice Nat. Biotechnol. 20 2002 1147 1150
43. E. Paramithiotis A prion protein epitope selective for the pathologically misfolded conformation Nat. Med. 9 2003 893 899
44. B. O'Nuallain, and R. Wetzel Conformational Abs recognizing a generic amyloid fibril epitope Proc. Natl. Acad. Sci. U. S. A. 99 2002 1485 1490
45. R. Kayed Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489
46. R. Hrncic Antibody-mediated resolution of light chain-associated amyloid deposits Am. J. Pathol. 157 2000 1239 1246
47. 1-40 accompanies the transition from dimer to fibril as revealed by fluorescence quenching analysis J. Biol. Chem. 275 2000 22645 22649
48. B. Caughey, and P.T. Lansbury Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders Annu. Rev. Neurosci. 26 2003 267 298
49. J. Shorter, and S. Lindquist Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers Science 304 2004 1793 1797
50. T.R. Serio, and S.L. Lindquist The yeast prion [PSI+]: molecular insights and functional consequences Adv Protein Chem 59 2001 391 412
51. S. Oddo Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction Neuron 39 2003 409 421
52. A. Sanbe Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis Proc. Natl. Acad. Sci. U. S. A. 101 2004 10132 10136